These animals presented augmented ALT, triglycerides, IL-1β and TNF-α levels and insulin resistance and the histological alterations of NASH such as collagen deposition, macro/microvesicular steatosis, and liver fibrosis. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.